Advertisement

Curious2018 pp 129-145 | Cite as

Accelerating Discovery with Cognitive—An Example Cognitive Application for Discovery: Watson for Drug Discovery

  • Scott SpanglerEmail author
Chapter

Abstract

Watson for Drug Discovery (WDD) is a cloud-based, end-to-end scalable platform that helps life science researchers discover new disease pathways, new drug targets, and additional drug indications. It ingests both structured and unstructured content from multiple internal and external heterogeneous sources. It then uses natural language processing and domain-specific ontologies to annotate this content so that the machine can read and understand the content more like the way a domain expert would.

References

  1. 1.
    Bakkar N et al. Artificial intelligence in neurodegenerative disease research: Use of Ibm Watson to identify additional rna-binding proteins altered in amyotrophic lateral sclerosis. Acta neuropathol. 2018;135.2:227–47. CrossRefGoogle Scholar
  2. 2.
    Johnston TH et al. Repurposing drugs to treat L-Dopa-induced dyskinesia in Parkinson’s disease. Neuropharmacology (2018).Google Scholar
  3. 3.
    Spangler S et al. Automated hypothesis generation based on mining scientific literature. In: Proceedings of the 20th ACM SIGKDD international conference on knowledge discovery and data mining. ACM; 2014.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.IBMSan MartinUSA

Personalised recommendations